Johnson Controls Launches Integrated Laboratory Services - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Johnson Controls Launches Integrated Laboratory Services



Johnson Controls announced an improved Integrated Laboratory Services (ILS) for the life-sciences market at Pittcon 2014, which includes a range of specialist solutions to help customers increase operational and financial efficiencies and manage risk within their R&D, manufacturing, data center, HQ, and warehousing facilities.

Johnson Controls is responsible for delivering IFM & lab services and supporting quality and compliance for 100 million ft2 of life-science facilities globally, with 40% of those facilities being regulated space.

The life-sciences team has developed a new scientific asset visualization tool, a reporting and analytics tool that enables data-driven decisions and delivers improved lab functions through dashboards and reports, interpreting various data sources, and utilizing its global data warehouse for Integrated Laboratory Services.

Source: Johnson Controls

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here